BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 4363386)

  • 1. In vitro demonstration of normal thyrotropin (TSH) responsiveness in thyroid tissue from patients with Graves' disease.
    Field JB; Larsen PR; Yamashita K
    Trans Assoc Am Physicians; 1973; 86():300-9. PubMed ID: 4363386
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of TSH on iodine metabolism and intermediary metabolism in tissue from patients with Graves' disease.
    Field JB; Larsen PR; Yamashita K; Chayoth R
    J Clin Endocrinol Metab; 1974 Nov; 39(5):942-9. PubMed ID: 4370784
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro demonstration of iodide-trapping defect but normal thyrotropin (TSH) responsiveness in benign and malignant "cold" thyroid nodules.
    Larsen PR; DeRubertis F; Yamashita K; Dekker A; Field JB
    Trans Assoc Am Physicians; 1972; 85():309-16. PubMed ID: 4349622
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of iodine enrichment in vitro on the adenylate cyclase-adenosine 3',5' monophosphate system in thyroid glands from normal subjects and patients with Graves' disease.
    Uchimura H; Chiu SC; Kuzaya N; Ikeda H; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1066-70. PubMed ID: 6246144
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell membrane of thyroid and its altered responsiveness to the hormone TSH.
    Macchia V; Meldolesi MF
    Adv Cytopharmacol; 1974; 2():33-7. PubMed ID: 4440562
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostaglandins and the thyroid gland.
    Mashiter K; Field JB
    Fed Proc; 1974 Jan; 33(1):78-80. PubMed ID: 4359039
    [No Abstract]   [Full Text] [Related]  

  • 7. TSH stimulation of 32P incorporation into phospholipids of thyroids from patients with Graves' disease.
    Schneider PB
    J Clin Endocrinol Metab; 1974 Jan; 38(1):148-50. PubMed ID: 4358643
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for normal thyroidal adenyl cyclase, cyclic AMP-binding and protein-kinase activities in Graves' disease.
    Orgiazzi J; Chopra IJ; Williams DE; Solomon DH
    J Clin Endocrinol Metab; 1975 Feb; 40(2):248-55. PubMed ID: 165418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adenylate cyclase-cyclic AMP system in Graves' disease.
    Field JB; Muto H; Chou MC
    Adv Cyclic Nucleotide Res; 1980; 12():359-72. PubMed ID: 6250367
    [No Abstract]   [Full Text] [Related]  

  • 10. [TSH and LATS].
    Ochi Y; Hachiya T; Shiomi K; Yoshimura M; Miyazaki T
    Saishin Igaku; 1972 May; 27(5):853-61. PubMed ID: 4339218
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies of thyroid glands of normal subjects and patients with Basedow's disease based on adenyl cyclase-cyclic AMP metabolism (III). Differences in reactions of the thyroid glands to TSH and PGE 1(2)].
    Takasu N; Sato M; Tsukui N; Yamada T; Miyakawa N
    Horumon To Rinsho; 1975 Oct; 23(10):1039-41. PubMed ID: 172264
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of thyroid-stimulating hormone on human thyroid carcinoma and adjacent normal tissue.
    Field JB; Bloom G; Chou MC; Kerins ME; Larsen PR; Kotani M; Kariya T; Dekker A
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1052-8. PubMed ID: 233688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodine metabolism in thyroid slices: effects of TSH, dibutyryl cyclic 3',5'-AMP, NaF and prostaglandin E-1.
    Ahn CS; Rosenberg IN
    Endocrinology; 1970 Feb; 86(2):396-405. PubMed ID: 4311906
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Influence of human thyroid-stimulating hormone and immunoglobulins from patients with Graves' disease on human thyroid cyclic AMP.
    Holmes SD; Dirmikis SM; Martin TJ; Munro DS
    J Endocrinol; 1976 Jun; 69(3):8P-9P. PubMed ID: 181521
    [No Abstract]   [Full Text] [Related]  

  • 15. Adenosine 3',5'-monophosphate concentrations and responsiveness to thyrotropin and thyroid-stimulating immunoglobulins in normal and Graves' thyroids.
    Kuzuya N; Uchimura H; Ikeda H; Chiu SC; Hamada N; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1980 Jul; 51(1):59-63. PubMed ID: 6247365
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies of adenyl cyclase-cyclic AMP of the thyroid gland of the normal man and in Basedow's disease. (II). Differences in reactions of the thyroid gland to TSH and PGE 1 stimulation].
    Takasu N; Sato S; Yamada T; Miyakawa S; Kawamura N
    Horumon To Rinsho; 1975 Sep; 23(9):913-6. PubMed ID: 1242704
    [No Abstract]   [Full Text] [Related]  

  • 17. Demonstration of iodide transport defect but normal iodide organification in nonfunctioning nodules of human thyroid glands.
    Field JB; Larsen PR; Yamashita K; Mashiter K; Dekker A
    J Clin Invest; 1973 Oct; 52(10):2404-10. PubMed ID: 4353998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of dietary iodine on the thyroid adenylate cyclase response to thyrotropin in the hypophysectomized rat.
    Rapoport B; West MN; Ingbar SH
    J Clin Invest; 1975 Aug; 56(2):516-9. PubMed ID: 168233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolysis in thyroid slices: Effects of TSH, dibutyryl cyclic 3', 5'-AMP and prostaglandin E.
    Ahn CS; Rosenberg IN
    Endocrinology; 1970 Apr; 86(4):870-3. PubMed ID: 4312985
    [No Abstract]   [Full Text] [Related]  

  • 20. Adenylate cyclase activity in thyroid tissue from patients with untreated Graves' disease.
    Kasagi K; Konishi J; Endo K; Mori T; Nagahara K; Makimoto K; Kuma K; Torizuka K
    J Clin Endocrinol Metab; 1980 Sep; 51(3):492-9. PubMed ID: 6893334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.